Vizora日本語

Shiseido×Rohto Pharmaceutical

Different ways of making money, on the same scale.

Same yardstick

MetricShiseidoFY ending Dec 2025Rohto PharmaceuticalFY ending Mar 2026
Revenue¥970B¥343.7B
COGS ratio23.4%43.9%
Operating margin-3.0%12.0%
Net margin-4.2%10.0%
FCF margin6.7%6.3%

Highlighted = best value for that metric

Compare industry percentiles by axis

Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.

  • ShiseidoPrimary industry: Cosmetics
  • Rohto PharmaceuticalPrimary industry: Cosmetics
CompanyRank

  • Revenue growth

    • Shiseido2522 peers
    • Rohto Pharmaceutical65.922 peers

  • Profitability

    • Shiseido13.526 peers
    • Rohto Pharmaceutical86.526 peers

  • Cash conversion

    • ShiseidoN/A
    • Rohto Pharmaceutical61.422 peers

  • Efficiency

    • Shiseido2526 peers
    • Rohto Pharmaceutical21.226 peers

  • Financial strength

    • ShiseidoN/A
    • Rohto PharmaceuticalN/A

Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.

Money flows side by side

Chart height is proportional to revenue.

Shiseido¥970B · keeps ¥-3 per ¥100
Rohto Pharmaceutical¥343.7B · keeps ¥12 per ¥100

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown